We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 22

Court grants summary judgment in Omnicare v. UnitedHealth Group

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 3 2009

The decision in this gun-jumping case emphasizes the importance of antitrust guidance during pre-closing due diligence and agreement negotiation

Court certifies class in hospital merger antitrust lawsuit

  • McDermott Will & Emery
  • -
  • USA
  • -
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action

Supreme Court limits availability of state action immunity from federal antitrust liability

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 20 2013

The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is

Court orders divestiture of consummated physician practice acquisition

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 14 2014

In a challenge brought both by private plaintiffs and the government, a court has ruled that a health system’s acquisition of a competing physician

North Carolina dentists seek rehearing en banc after losing bid for antitrust immunity

  • McDermott Will & Emery
  • -
  • USA
  • -
  • July 19 2013

North Carolina's dentists were not smiling when a three judge panel of the U.S. Court of Appeals for the Fourth Circuit sided with the Federal Trade

U.S. Supreme Court hears oral argument in Phoebe Putney hospital merger challenge

  • McDermott Will & Emery
  • -
  • USA
  • -
  • November 27 2012

In oral argument in FTC v Phoebe Putney Health System, Supreme Court Justices focused on whether the state legislature clearly articulated a state policy to displace competition with regulation, in a case challenging the application of the state action doctrine to a hospital merger to monopoly

Reverse payment settlements

  • McDermott Will & Emery
  • -
  • USA
  • -
  • November 7 2011

On Monday, a California state court of appeal affirmed a lower court's ruling upholding a "reverse payment" (pay-for-delay) settlement between Bayer (Bayer) AG and Barr Pharmaceuticals (Barr

GlaxoSmithKline infringed competition rules by restricting parallel trade

  • McDermott Will & Emery
  • -
  • European Union, Greece
  • -
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers

Supreme Court hears oral argument in pay-for-delay patent settlement antitrust case

  • McDermott Will & Emery
  • -
  • USA
  • -
  • March 26 2013

The Supreme Court's ruling in Federal Trade Commission v. Actavis, Inc., will almost certainly have major implications for the viability of Federal

Market definition spurs district court’s decision denying product ownership challenge

  • McDermott Will & Emery
  • -
  • USA
  • -
  • September 22 2010

The Federal District Court in Minnesota recently decided Ovation Pharmaceutical did not violate federal or state antitrust laws when it acquired Indocin IV and NeoProfen, the only two drugs approved for treatment of a specific heart condition that primarily affects premature babies, because the challengers failed to establish that the drugs were in the same product market